Back to funds
View filing
PFIZER INC
institutionalUpdated 28 days agoManaged by Pfizer Inc • Latest filing Q2 2026
Portfolio value
$170.4M
Q2 2026
Filings
7
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-90.9%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 7 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2024 | $2.6B |
| Q1 2025 | $500.8M |
| Q2 2025 | $576.2M |
| Q3 2025 | $437.5M |
| Q4 2025 | $236.5M |
| Q1 2026 | $238.8M |
| Q2 2026 | $170.4M |
Top holdings
20 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A ALLO ALLOGENE THERAPEUTICS INC | $46.9M | 22.03M | 27.55% | — |
| 2 | C CELC CELCUITY INC | $29.6M | 295.7K | 17.35% | — |
| 3 | A ARVN ARVINAS INC | $27.7M | 3.46M | 16.24% | — |
| 4 | Q QUBT PYXIS ONCOLOGY INC | $16.5M | 5.95M | 9.68% | — |
| 5 | W WVE WAVE LIFE SCIENCES LTD | $10.9M | 1.88M | 6.42% | — |
| 6 | B BHVN BIOHAVEN LTD | $8M | 505.6K | 4.70% | — |
| 7 | ? N/A CARIBOU BIOSCIENCES INC | $7.9M | 4.69M | 4.63% | — |
| 8 | ? N/A SPERO THERAPEUTICS INC | $5.3M | 2.36M | 3.13% | — |
| 9 | ? N/A ZENTALIS PHARMACEUTICALS INC | $3.9M | 953.8K | 2.26% | — |
| 10 | O ORIC ORIC PHARMACEUTICALS INC | $3.6M | 372.9K | 2.09% | — |
| 11 | ? N/A CARDIFF ONCOLOGY INC | $3M | 2.41M | 1.77% | — |
| 12 | Q QUBT PYXIS ONCOLOGY INC | $3M | 1.08M | 1.76% | — |
| 13 | Z ZURA ZURA BIO LTD | $2.9M | 538.8K | 1.69% | — |
| 14 | A AGMB AGOMAB THERAPEUTICS NV | $1M | 75.0K | 0.61% | — |
| 15 | ? N/A BOLT BIOTHERAPEUTICS INC | $134K | 31.3K | 0.08% | — |
| 16 | N NXTC NEXTCURE INC | $61K | 37.3K | 0.04% | — |
| 17 | D DNABW GINKGO BIOWORKS HOLDINGS INC | $27K | 2.7K | 0.02% | — |
| 18 | S SENS SENSEONICS HLDGS INC | $12K | 2.2K | 0.01% | — |
| 19 | N NXTC NEXTCURE INC | $12K | 7.0K | 0.01% | — |
| 20 | D DNABW GINKGO BIOWORKS HOLDINGS INC | $3K | 247 | 0.00% | — |